Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
4.550
-0.210 (-4.41%)
At close: Mar 18, 2026, 4:00 PM EDT
4.510
-0.040 (-0.88%)
After-hours: Mar 18, 2026, 7:54 PM EDT
Abeona Therapeutics Employees
Abeona Therapeutics had 226 employees as of December 31, 2025. The number of employees increased by 90 or 66.18% compared to the previous year.
Employees
226
Change (1Y)
90
Growth (1Y)
66.18%
Revenue / Employee
$42,794
Profits / Employee
$523,404
Market Cap
259.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 226 | 90 | 66.18% |
| Dec 31, 2024 | 136 | 52 | 61.90% |
| Dec 31, 2023 | 84 | 27 | 47.37% |
| Dec 31, 2022 | 57 | -33 | -36.67% |
| Dec 31, 2021 | 90 | 14 | 18.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| C4 Therapeutics | 104 |
| OmniAb | 89 |
| Orchestra BioMed Holdings | 70 |
| Camp4 Therapeutics | 55 |
| Cybin | 50 |
| ALX Oncology Holdings | 44 |
| Avalo Therapeutics | 23 |
ABEO News
- 1 day ago - Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 9 days ago - Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch - GlobeNewsWire
- 15 days ago - Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - GlobeNewsWire